EDWARDS LIFESCIENCES PERIMOUNT AORTIC AND MITRAL BIOPROSTHESES
Edwards Lifesciences, LLC · Decision date Sep 26, 1991
What did the FDA approve?
This FDA database entry records an original PMA approval for the Carpentier-Edwards Pericardial Bioprosthesis, Model 2700, granted to Edwards Lifesciences, LLC on September 26, 1991. The decision field is labeled APPR, and the statement identifies the approved device as a replacement heart-valve under product code DYE in the cardiovascular specialty.
The source statement describes the device's intended use as replacing a natural aortic valve when aortic valvular disease is sufficiently advanced, and as replacing a previously implanted aortic valve prosthesis that is no longer functioning adequately. The entry does not include supplement type, supplement reason, or any independent safety or effectiveness data. The statement's reported purpose is distinct from proof of clinical performance.
FDA approval order statement
Approval for the Carpentier-Edwards Pericardial Bioprosthesis, Model 2700. This device is intended for use in patients whose aortic valvular disease is sufficiently advanced to warrant replacement of their natural valve with a prosthetic one. It is also intended for use in patients with a previously implanted aortic valve prosthesis that is no longer functioning adequately and requires replacement.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 26, 1991
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P860057
- Regulatory pathway
- Premarket approval application
- Applicant
- Edwards Lifesciences, LLC
- Product code
- DYE
- Decision code
- APPR
- Decision date
- Sep 26, 1991
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: replacement Heart-valve.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- DYE
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P860057 received
Application receipt date recorded by FDA.
P860057 · FDA decision
APPR
P860057/S228 · Related supplement
Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process (2800TFX), Carpen
Timeline entries are records held by MedtechLedger for P860057. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P860057
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P860057
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records